Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
262
-
Total 13F shares, excl. options
-
47,330,397
-
Shares change
-
+2,243,311
-
Total reported value, excl. options
-
$2,039,414,220
-
Value change
-
+$105,035,296
-
Put/Call ratio
-
64%
-
Number of buys
-
142
-
Number of sells
-
-119
-
Price
-
$43.10
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2017
302 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2017.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,330,397 shares
of 56,047,431 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,727,641 shares), VANGUARD GROUP INC (3,500,535 shares), Invesco Ltd. (2,235,905 shares), ACADIAN ASSET MANAGEMENT LLC (1,557,544 shares), Bank of New York Mellon Corp (1,546,329 shares), STATE STREET CORP (1,397,484 shares), RICE HALL JAMES & ASSOCIATES, LLC (1,361,373 shares), DIMENSIONAL FUND ADVISORS LP (1,268,082 shares), ROTHSCHILD ASSET MANAGEMENT INC (1,172,865 shares), and Ranger Investment Management, L.P. (1,113,255 shares).
This table shows the top 262 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.